SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION

12 Months Ended

Dec. 31, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION

NOTE 12 - SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION:

Balance sheets:

Inventory:

	December 31,
	2023		2022
	($ in thousands)
Finished goods	$	210	$	179
Work in process		562		510
Raw materials and supplies		1,334		932
	$	2,106	$	1,621

a. Accounts payable and accruals-other:

	December 31,
	2023		2022
	($ in thousands)
Employees and employee institutions	$	2,188	$	1,853
Accrued vacation and recreation pay		287		197
Accrued expenses		1,115		554
Clinical trial accrual		744		1,258
Current Operating lease liabilities		557		419
Other		190		130
	$	5,081	$	4,411